PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2

References

• Aliabadi, H.S., Karimimanesh, A., and Varshosaz, J., 2013. Biological effects of letrozole-loaded lipid nanocapsules on MCF-7 cell line. Journal of Isfahan medical school, 30 (217), 2169–2177.
   Google Scholar
• Amselem, S., et al., 1994. Emulsomes, a novel drug delivery technology. Proceeding of international symposium of controlled release of bioactive materials, 1368–1369.
   Google Scholar
• Blaker, M., et al., 2004. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas. Journal of hepatology, 41 (1), 112–118.
   PubMed Web of Science ®Google Scholar
• Bruix, J. and Sherman, M., 2005. Management of hepatocellular carcinoma. Hepatology (Baltimore, Md.), 42 (5), 1208–1236.
   PubMed Web of Science ®Google Scholar
• Cheng, A.L., et al., 2009. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. The lancet oncology, 10 (1), 25–34.
   PubMed Web of Science ®Google Scholar
• Epelbaum, J., 1986. Somatostatin in the central nervous system: physiology and pathological modifications. Progress in neurobiology, 27 (1), 63–100.
   PubMed Web of Science ®Google Scholar
• Forner, A., Llovet, J.M., and Bruix, J., 2012. Hepatocellular carcinoma. Lancet (London, England), 379 (9822), 1245–1255.
   PubMed Web of Science ®Google Scholar
• Ganten, T.M., et al., 2017. Sorafenib in patients with hepatocellular carcinoma-results of the observational insight study. Clinical cancer research, 23 (19), 5720–5728.
   PubMed Web of Science ®Google Scholar
• Gill, B., et al., 2012. Emulsomes: an emerging vesicular drug delivery system. Asian journal of pharmaceutics, 6 (2), 87–94.
   Google Scholar
• Guhagarkar, S.A., et al., 2010. Polyethylene sebacate–doxorubicin nanoparticles for hepatic targeting. International journal of pharmaceutics, 401 (1–2), 113–122.
   PubMed Web of Science ®Google Scholar
• Gulec, S.A., et al., 2001. Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with 111In-DTPA-JIC 2DL. Journal of surgical research, 97 (2), 131–137.
   PubMed Web of Science ®Google Scholar
• Gupta, L., et al., 2017. Dendrimer encapsulated and conjugated delivery of berberine: a novel approach mitigating toxicity and improving in vivo pharmacokinetics. International journal of pharmaceutics, 528 (1–2), 88–99.
   PubMed Web of Science ®Google Scholar
• Hua, Y.P., et al., 2009. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma. Chemotherapy, 55 (5), 312–320.
   PubMed Web of Science ®Google Scholar
• Jemal, A. and Torre, L.A., 2017. The global burden of cancer. In: The American Cancer Society (Editor). The American cancer society's principles of oncology: prevention to survivorship, Wiley-Blackwell Publisher, pp. 33–44.
   Google Scholar
• Karami, N., et al., 2018. Liposomes as a novel drug delivery system: fundamental and pharmaceutical application. Asian journal of pharmaceutics, 12 (1), S31–S41.
   Web of Science ®Google Scholar
• Kim, D.H., et al., 2012. Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly (dl-lactide-co-glycolide) block copolymer. Nanoscale research letters, 7 (1), 91.
   PubMedGoogle Scholar
• Kumar, R. and Seth, N., 2013. Emulsomes: an emerging vesicular drug delivery system. Journal of drug delivery and therapeutics, 3 (6), 133–142.
   Google Scholar
• Kuo, Y.C. and Shih, K.H., 2009. Loading efficiency and surface conductance of heparin-modified poly(lactide-co-glycolide) nanoparticles. Colloidal surfaces B: biointerfaces, 71 (2), 282–287.
   PubMed Web of Science ®Google Scholar
• Lin, T.T., et al., 2016. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis. Journal of controlled release, 221, 62–70.
   PubMed Web of Science ®Google Scholar
• Liu, C., et al., 2016. Improving oral bioavailability of sorafenib by optimizing the “spring and parachute based on molecular interaction mechanisms. Molecular pharmaceutics, 13 (2), 599–608.
   PubMed Web of Science ®Google Scholar
• Llovet, J.M., Burroughs, A., and Bruix, J., 2003. Hepatocellular carcinoma. Lancet (London, England), 362 (9399), 1907–1917.
   PubMed Web of Science ®Google Scholar
• Llovet, J.M., et al., 2008. Sorafenib in advanced hepatocellular carcinoma. The New England journal of medicine, 359 (4), 378–390.
   PubMed Web of Science ®Google Scholar
• Madhusudhan, A., et al., 2014. Efficient pH dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosan. International journal of molecular sciences, 15 (5), 8216–8234.
   PubMed Web of Science ®Google Scholar
• Maluccio, M. and Covey, A., 2012. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA: a cancer journal of clinicians, 62 (6), 394–399.
   PubMed Web of Science ®Google Scholar
• Møller, L.N., et al., 2003. Somatostatin receptors. Biochimica et biophysica acta, 1616 (1), 1–84.
   PubMed Web of Science ®Google Scholar
• Mourya, V. and Inamdar, N.N., 2009. Trimethyl chitosan and its applications in drug delivery. Journal of materials science: materials in medicine, 20 (5), 1057–1079.
   PubMed Web of Science ®Google Scholar
• Nair, A., et al., 2013. Emulsomes: a novel liposomal formulation for sustained drug delivery. Interntional research journal of pharmaceutical applied sciences, 3 (5), 192–196.
   Google Scholar
• Ranieri, G., et al., 2012. Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development. Current medicinal chemistry, 19 (7), 938–944.
   PubMed Web of Science ®Google Scholar
• Reisine, T. and Bell, G., 1995. Molecular properties of somatostatin receptors. Neuroscience, 67 (4), 777–790.
   PubMed Web of Science ®Google Scholar
• Reubi, J.C., 2003. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine reviews, 24 (4), 389–427.
   PubMed Web of Science ®Google Scholar
• Rudra, A., et al., 2010. Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats. International journal of nanomedicine, 5, 811.
   PubMed Web of Science ®Google Scholar
• Saraswathy, M., et al., 2015. Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy. Colloidal surface B: biointerfaces, 126, 590–597.
   PubMed Web of Science ®Google Scholar
• Sieval, A., et al., 1998. Preparation and NMR characterization of highly substitutedN-trimethyl chitosan chloride. Carbohydrate polymer, 36 (2–3), 157–165.
   Web of Science ®Google Scholar
• Silva, J.O., et al., 2016. pH-sensitive, long-circulating liposomes as an alternative tool to deliver doxorubicin into tumors: a feasibility animal study. Molecular imaging and biology, 18 (6), 898–904.
   PubMed Web of Science ®Google Scholar
• Smith, J., Wood, E., and Dornish, M., 2004. Effect of chitosan on epithelial cell tight junctions. Pharmaceutical research, 21 (1), 43–49.
   PubMed Web of Science ®Google Scholar
• Sonvico, F., et al., 2006. Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. International journal of pharmaceutics, 324 (1), 67–73.
   PubMed Web of Science ®Google Scholar
• Sun, L.C. and Coy, D.H., 2011. Somatostatin receptor-targeted anti-cancer therapy. Current drug delivery, 8 (1), 2–10.
   PubMed Web of Science ®Google Scholar
• Sung, Y.C., et al., 2018. Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development. Theranostics, 8 (4), 894–905.
   PubMed Web of Science ®Google Scholar
• Taylor, J.E., et al., 1994. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity. Peptides, 15 (7), 1229–1236.
   PubMed Web of Science ®Google Scholar
• Thanou, M., et al., 2000. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. Journal of pharmaceutical sciences, 89 (7), 951–957.
   PubMed Web of Science ®Google Scholar
• Thanou, M.M., et al., 1999. Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on Caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea. International journal of pharmaceutics, 185 (1), 73–82.
   PubMed Web of Science ®Google Scholar
• Ucisik, M.H., Sleytr, U.B., and Schuster, B., 2015. Emulsomes meet S-layer proteins: an emerging targeted drug delivery system. Current pharmaceutical biotechnology, 16 (4), 392–405.
   PubMed Web of Science ®Google Scholar
• Varshosaz, J., et al., 2014. Uptake of etoposide in CT-26 cells of colorectal cancer using folate targeted dextran stearate polymeric micelles. BioMedical research international, 2014, 1.
   Web of Science ®Google Scholar
• Varshosaz, J., et al., 2017. Synthesis of biotin-targeted chitosan/poly (methyl vinyl ether-alt-maleic acid) copolymeric micelles for delivery of doxorubicin. IET nanobiotechnology, 11 (7), 843–851.
   Web of Science ®Google Scholar
• Varshosaz, J., Davoudi, A., and Rasoul-Amini, S., 2018. Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells. Journal of liposome research, 28 (4), 285–295.
   PubMed Web of Science ®Google Scholar
• Varshosaz, J., et al., 2018. Poly (butylene adipate-co-terephthalate) electrospun nanofibers loaded with 5-fluorouracil and curcumin in treatment of colorectal cancer cells. Polymer testing, 65, 217–230.
   Web of Science ®Google Scholar
• Vyas, S.P., Rasika, S., and Sanyog, J., 2006. Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. The journal of pharmacy and pharmacology, 58 (3), 321–326.
   PubMed Web of Science ®Google Scholar
• Wang, S., et al., 2010. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting. International journal of pharmaceutics, 386 (1–2), 249–255.
   PubMed Web of Science ®Google Scholar
• Wang, J.J., et al., 2011. Recent advances of chitosan nanoparticles as drug carriers. International journal of nanomedicine, 6, 765.
   PubMed Web of Science ®Google Scholar
• Watson, J., et al., 2001. Growing vascular endothelial cells express somatostatin subtype 2 receptors. British journal of cancer, 85 (2), 266.
   PubMed Web of Science ®Google Scholar
• Watt, H.L., Kharmate, G., and Kumar, U., 2008. Biology of somatostatin in breast cancer. Molecular and cellular endocrinology, 286 (1–2), 251–261.
   PubMed Web of Science ®Google Scholar
• Yao, X., et al., 2017. Graphene quantum dots‐capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy. Small, 13 (2), 1602225.
   Web of Science ®Google Scholar
• Zhang, Z. and Feng, S.S., 2006. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly (lactide)–tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials, 27 (21), 4025–4033.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2010. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models. Molecular pharmaceutics, 7 (4), 1159–1168.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2016. iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy. Nanomedicine, nanotechnology and biological medicine, 12 (5), 1303–1311.
   PubMed Web of Science ®Google Scholar
• Zhao, M., et al., 2014. Clickable protein nanocapsules for targeted delivery of recombinant p53 protein. Journal of the American chemical society, 136 (43), 15319–15325.
   PubMed Web of Science ®Google Scholar
• Zhu, M., et al., 2017. Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells. Nanomedicine (London, England), 12 (4), 295–315.
   PubMed Web of Science ®Google Scholar